Ophthalmologist in Fairfax

CentraSight in Fairfax

Ophthalmologist in Fairfax

Ophthalmologist in Fairfax

If you are looking for an excellent eye care practice that can provide you with exceptional treatment for retinal problems, you will want to come and visit us at The Retina Group of Washington. At our practice we offer leading edge technology and treatment by our expert ophthalmologists, including treatment with CentraSight for patients with advanced macular degeneration (AMD). When you are looking for the very best ophthalmologists in Fairfax, you simply need to make an appointment at our office.

At our Fairfax office of The Retina Group of Washington, our top-notch ophthalmologists are: Dr. Daniel M. Berinstein; Dr. Marcus H. Colyer; Dr. William F. Deegan, III; Dr. Richard A. Garfinkel; Dr. Alexander Melamud; Dr. John R. Minarcik; Dr. Robert P. Murphy; Dr. Michael H. Osman; Dr. Michael F. Rivers; and Dr. Manfred A. vonFricken. Our practice is happy to be able to offer treatment with CentraSight, a treatment for individuals affected by end-stage age related macular degeneration. This treatment is actually a tiny telescope which is implanted inside the eye. This leading-edge technology is approved by the FDA. This implantable telescope is able to minimize the impact on central blindness that is caused by the AMD. The technology works by actually projecting the object the patient is trying to see onto the healthy area of the retina that has not been affected by the age-related macular degeneration. Our ophthalmologist in Fairfax has found this treatment to be very effective and helpful for patients in end-stage macular degeneration who qualify for the procedure.

The telescope that is implanted by our ophthalmologist is about the size of a pea. It is very effective in improving distance and near vision, and is used for patients who have lost central vision is in both eyes from end-stage AMD. The telescope is implanted inside the eye that provides central vision. The other eye provides peripheral vision. Patients eligible for this procedure have irreversible, end-stage AMD, and are no longer a good candidate for drug treatment of AMD. This treatment is not effective for patients who have had cataract surgery in the eye which will contain the implanted device. Our ophthalmologist will need to perform several tests to see if you are a good candidate for receiving this device. For more information regarding CentraSight treatment, and to determine whether or not this is a good treatment option for you, make an appointment to meet with our ophthalmologist in Fairfax.

The Retina Group of Washington
8505 Arlington Blvd, Suite 300
Fairfax, VA 22031-4621
(703) 698-9335